BIOMARIN PHARMACEUTICAL INC (BMRN) Income Tax Expense (Benefit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $16.9 M, a 186% increase year-over-year.
  • Biomarin Pharmaceutical Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $31.9 M, a 5907% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Income Tax Expense (Benefit) for 2023 was $20.9 M, a 161% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Income Tax Expense (Benefit) for 2022 was $8.02 M.
  • Biomarin Pharmaceutical Inc annual Income Tax Expense (Benefit) for 2021 was -$11.3 M, a 98.8% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $31.9 M $16.9 M +$11 M +186% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $20.9 M -$1.05 M +$16.3 M +93.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $4.66 M $1.29 M -$3.46 M -72.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $8.11 M $14.8 M +$7.58 M +106% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $531 K $5.91 M -$7.48 M -55.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $8.02 M -$17.3 M -$8.63 M -99.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $16.6 M $4.75 M +$14.4 M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $2.23 M $7.19 M +$5.97 M +492% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$3.74 M $13.4 M +$7.53 M +129% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 -$11.3 M -$8.68 M +$55.2 M +86.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$66.5 M -$9.67 M +$836 M +98.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 -$903 M $1.22 M +$14.3 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$917 M $5.86 M -$14.1 M -70.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 -$903 M -$63.9 M -$39.1 M -158% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$864 M -$846 M -$801 M -1771% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 -$63.1 M -$13.1 M -$8.63 M -193% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 -$54.5 M $20 M +$16.5 M +468% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 -$71 M -$24.8 M +$14.9 M +37.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$85.8 M -$45.2 M -$38.4 M -566% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$47.4 M -$4.46 M +$7.93 M +64% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$55.3 M $3.52 M +$10.2 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 -$65.5 M -$39.7 M -$146 M -137% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $80.2 M -$6.79 M +$1.3 M +16.1% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 $78.9 M -$12.4 M -$3.67 M -42.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $82.5 M -$6.66 M +$1.36 M +17% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $81.2 M $106 M +$107 M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$26.3 M -$8.09 M +$21.3 M +72.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 -$47.6 M -$8.71 M +$155 M +94.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$203 M -$8.02 M -$1.94 M -32% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 -$201 M -$1.45 M -$25.8 M -106% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$175 M -$29.4 M -$29.9 M -6184% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$145 M -$164 M -$163 M -29490% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $18.2 M -$6.08 M +$1.13 M +15.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $17.1 M $24.3 M +$20.3 M +500% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 -$3.21 M $483 K +$4.71 M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$7.92 M -$554 K -$6.33 M -110% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$1.59 M -$7.2 M -$10.7 M -306% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $9.1 M $4.06 M +$1.45 M +55.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $7.66 M -$4.22 M -$4.93 M -700% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $12.6 M $5.77 M +$4.53 M +365% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $8.05 M $3.49 M +$8.2 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$150 K $2.62 M -$303 K -10.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $153 K $704 K +$7.11 M Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 -$6.96 M $1.24 M +$1.65 M Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 -$8.61 M -$4.71 M -$4.68 M -13756% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 -$3.93 M $2.92 M -$701 K -19.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$3.23 M -$6.4 M -$4.33 M -208% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $1.1 M -$411 K -$4.32 M -111% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 $5.41 M -$34 K -$4.8 M -101% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q4 2011 $10.2 M $3.62 M +$10.7 M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 -$459 K -$2.08 M +$220 M +99.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-29
Q2 2011 -$220 M $3.9 M +$2.85 M +270% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 -$223 M $4.76 M +$4.13 M +649% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 -$227 M -$7.05 M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 -$222 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $1.06 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $636 K Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.